¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"chronic hypertrophic emphysema"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • progressive hypertrophic interstitial neuritis
    ÁøÇ༺ ºñÈļº °£Áú¼º ½Å°æ¿°(¡­ãêÌèæú).
  • progressive hypertrophic interstitial neuritis
    ÁøÇ༺ ºñÈļº °£Áú¼º ½Å°æ¿°(òäú¼àõ Ýþý§àõ ÊÖòðàõ ãêÌèæú)
  • pulmonary hypertrophic osteopathy
    Æó¼º ºñ´ë¼º °ñº´Áõ.
  • pulmonary hypertrophic osteopathy
    Æó¼ººñ´ë¼º °ñº´Áõ(øËàõÝþÓÞàõ ÍéÜ»ñø)
  • rhinitis, hypertrophic
    ºñÈÄ(¼º) ºñ¿°
  • secondary hypertrophic osteoarthropathy
    ¼Ó¹ß¼º ºñ´ë¼º °ñ°üÀýº´Áõ(¡­ÝþÓÞàõ Íéμï½Ü»ñø).
  • secondary hypertrophic osteoarthropathy
    ¼Ó¹ß¼º ºñ´ë¼º °ñ°üÀýº´Áõ(¡­ÝþÓÞàõ Íéμï½Ü»ñø)
  • alcoholism, chronic
    ¾ËÄÚ¿Ã Áßµ¶, ¸¸¼º(¡­ñéÔ¸)
  • brain syndrome, acute, chronic
    ±Þ¼º, ¸¸¼º ³úÁõÈıº.
  • bronchitis, chronic
    ±â°üÁö¿°(¡­æú), ¸¸¼º(Ø·àõ)
  • carrier, chronic
    ¸¸¼ºº¸±ÕÀÚ
  • chronic
    ¸¸¼ºÀÇ
  • chronic acholuric jaundice
    ¸¸¼º¹«´ã»ö¼Ò´¢¼º Ȳ´Þ(¡­ÙíÓÅßäáÈèñàõüÜÓ¸).
  • chronic acholuric jaundice
    ¸¸¼º¹«´ã»ö¼Ò´¢¼º Ȳ´Þ(¡­ÙíÓÅßäáÈèñàõüÜÓ¸)
  • chronic acral dermatitis
    ¸¸¼º ¸»´Ü ÇǺο°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
HIT hemagglutination inhibition test; heparin-induced thrombocytopenia; histamine inhalation test; hyper...
HMSAS hypertrophic muscular subaortic stenosis
HN head and neck; head nurse; hemagglutinin neuraminidase; hematemesis neonatorum; hemorrhage of newbor...
HOA hip osteoarthritis; hypertrophic osteoarthropathy
HOCM high-osmolar contrast medium; hypertrophic obstructive cardiomyopathy
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
CRF CHRONIC RENAL FAILURE
CAH Chronic Active Hepatitis
C.A.H. Chronic Aggressive Hepatitis
CAO Chronic Airflow Obstruction
CADI Chronic Allograft Damage Index
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • chronic sinusitis
    ¸¸¼º »ó¾Çµ¿¿°
    »ó¾Çµ¿¿¡ »ý±â´Â ¸¸¼º ¿°ÁõÀÌ´Ù. ´ç´¢ ȯÀÚ¿¡¼­ ±Þ¼º, ¸¸¼º »ó¾Çµ¿¿°½Ã Á¶±ÕÁõÀÇ ¿°Áõ¿¡ ÁÖÀÇÇØ¾ß ÇÑ´Ù. Á¶¼Ò´Â ¿ëÁ¾
  • chronic slow viral encephalitis
    ¸¸¼º Áö¿¬Çü ¹ÙÀÌ·¯½º¼º ³ú¿°
  • chronic subdural hemorrhage
    ¸¸¼º °æ¸·ÇÏ ÃâÇ÷
  • chronic superficial gastritis
    ¸¸¼º Ç¥À缺 À§¿°
  • chronic suppurative osteomyelitis
    ¸¸¼º È­³ó¼º °ñ¼ö¿°
    ±Þ¼º¿¡ ºñÇØ ¸ðµç Áõ»óÀÌ ¾àÇÏ´Ù. ±Þ¼ºÀ¸·Î ¾ÇÈ­°¡ ÁÖ±âÀûÀ¸·Î µÈ´Ù. Ä¡·á´Â Àß ¾ÈµÇ°í Àç¹ßÀÌ ½±´Ù.
  • chronic syndromes
    ¸¸¼º ÁõÈıº
  • chronic thyroiditis
    ¸¸¼º °©»ó¼±¿°
  • chronic toxicity
    ¸¸¼º µ¶¼º
  • chronic ulcer
    ¸¸¼º ±Ë¾ç
  • chronic ulcerative pulpitis
    ¸¸¼º ±Ë¾ç¼º Ä¡¼ö¿°
    ³ëÃâµÈ Ä¡¼ö Ç¥¸é¿¡ ³ó¾ç Çü¼º Áï ±Ë¾çÀÌ Æ¯Â¡ÀÌ´Ù. ¸¸¼º ¿°Áõ »óÅÂ. ÀþÀº »ç¶÷ÀÇ Ä¡¼ö, ³ªÀ̰¡ ¸¹Àº »ç¶÷¿¡¼­ ¾àÇÑ °¨¿°¿¡ ÀúÇ×ÇÒ ¸¸ÇÑ °Ç°­ÇÑ Ä¡¼ö¿¡ º¼ ¼ö ÀÖ´Ù.
  • chronic urethritis
    ¸¸¼º ¿äµµ¿°
  • chronic vasometer instability
    ¸¸¼º Ç÷°ü ¿îµ¿ ºÒ¾ÈÁ¤, ¸¸¼º Ç÷°ü ¿îµ¿ ºÒ¾ÈÁ¤Áõ
  • familial benign chronic pemphigus
    °¡Á·¼º ¾ç¼º ¸¸¼º õÆ÷â
  • following chronic infectious disease
    ¸¸¼º °¨¿° ÁúȯÀÇ ÃßÀû
  • pemphigus chronic vulgaris
    ¸¸¼º ½É»ó¼º õÆ÷â
    ÀÚ°¡ ¸é¿ª¼º ¼öÆ÷¼º ÁúȯÀ¸·Î¼­ ÁÖ·Î ÇÇºÎ¿Í Á¡¸·¿¡ ¹ß»ýÇÑ´Ù. Ư¡Àû ÀÚ°¡ Ç×üÀÇ ¸ñÇ¥ ÁöÁ¡Àº »óÇÇÀÇ ¼¼Æ÷°£±³ º¹ÇÕüÀÌ´Ù. ÀÌ·¯ÇÑ Á¶Á÷°ú ÀÚ°¡ Ç×ü°¡ ¹ÝÀÀÇϸé, ¼¼Æ÷ °áÇÕÀÌ ÆÄ±«µÇ¾î »óÆÐÀÇ ºÐ¸®°¡ ¾ß±âµÈ´Ù. À¯ÀüÀû ¿äÀÎÀÌ ÀÌ Áúȯ°ú °ü·Ã ÀÖ´Ù. ½É»ó¼º õÆ÷âÀÇ Ç¥ÇÇ ¹× Á¡¸· ¼Ò°ßÀº ÀϽÃÀûÀ̸ç, ¸¼Àº ¼ö¾×À¸·Î ä¿öÁø ¼Ò¼öÆ÷ ¹× ¼öÆ÷°¡ ³ªÅ¸³µ´Ù°¡ ÅÍÁüÀ¸·Î¼­ ±Ë¾çÀÌ µÇ´Âµ¥ ºÎºÐÀûÀ¸·Î´Â À¯¾àÇÑ ¸·À¸·Î µ¤¿©Áø °ÍÀ» º¼ ¼ö ÀÖ´Ù. ´ëºÎºÐÀÇ È¯ÀÚ´Â Áß³â ÀÌÈÄ¿¡ ³ªÅ¸³ªÁö¸¸ ¾î¸°À̳ª ÀþÀºÀÌ¿¡°Ôµµ ¹ß»ý ÇÒ ¼ö ÀÖ´Ù. ´ëºÎºÐÀÇ ÀÚ°¡ ¸é¿ª Áúȯ°ú ¸¶Âù°¡Áö·Î Ä¡·á´Â ÄÚ¸®Æ¼ÄÚ ½ºÅ×·ÎÀ̵带 ±¹¼Ò µµÆ÷ ¹× Àü½Å Åõ¿©ÇÏ´Â µî ¸é¿ª¾ïÁ¦Á¦¿¡ ÀÇÁ¸ÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
chronic eosinophilic pneumonia <radiology> Idiopathic, associated with allergies and desensitization, variant of Loeffler pneumonia, treatment: corticosteroids Findings: reverse pulmonary oedema pattern (= Loeffler's), areas of consolidation persists (days to weeks) see: eosinophilic lung disease
(12 Dec 1998)
chronic familial icterus <haematology> A hereditary disorder that leads to a chronic haemolytic anaemia due to an abnormality in the red blood cell membrane.
This disorder is caused by a defective gene. Red cells are resistant to stress and rupture easily. Infants may appear jaundiced and pale. Fatigue, weakness and shortness of breath are other symptoms that may be seen in older patients. The spleen may also be enlarged.
Treatment includes splenectomy (removal of the spleen). After this is accomplished the life-span of the red blood cells returns to normal.
(27 Sep 1997)
chronic familial jaundice <haematology> A hereditary disorder that leads to a chronic haemolytic anaemia due to an abnormality in the red blood cell membrane.
This disorder is caused by a defective gene. Red cells are resistant to stress and rupture easily. Infants may appear jaundiced and pale. Fatigue, weakness and shortness of breath are other symptoms that may be seen in older patients. The spleen may also be enlarged.
Treatment includes splenectomy (removal of the spleen). After this is accomplished the life-span of the red blood cells returns to normal.
(27 Sep 1997)
chronic familial polyneuritis Inflammation of nerves related to infiltration by amyloid.
(05 Mar 2000)
chronic fatigue syndrome <syndrome> An unusual illness, of uncertain cause, that is characterised by unexplained fatigue, weakness, muscle pain, lymph node swelling and malaise.
(27 Sep 1997)
chronic fibrosing alveolitis <radiology> Aka: usual interstitial pneumonia (UIP), 5-6th decade; M:F = 1:1, clubbing of fingers (83%), lymphocytosis on lavage, increased occurence of bronchogenic CA, average survival of 4-6 years; 87% mortality CXR findings: occasional ground glass pattern in early stage of alveolitis, diffuse reticulations (60%) predominantly at bases, honeycombing, pleural effusion (4%); pleural thickening (6%), pneumothorax in 7% (late stage), progressive volume loss see: interstitial pulmonary fibrosis
(12 Dec 1998)
chronic fibrous thyroiditis A rare fibrous induration of the thyroid gland, with adhesion to adjacent structures, which may cause tracheal compression.
Synonym: chronic fibrous thyroiditis, ligneous struma, ligneous thyroiditis, Riedel's disease, Riedel's struma.
(05 Mar 2000)
chronic focal sclerosing osteomyelitis A reaction of bone to a mild bacterial infection, often the result of a carious tooth, in persons with a high degree of tissue resistance; results in a localised radio-opacity.
Synonym: focal condensing osteitis.
(05 Mar 2000)
chronic follicular conjunctivitis Indolent inflammation of the conjunctiva, with discrete follicles in fornices that may be infective, toxic, or irritant in nature.
(05 Mar 2000)
chronic glaucoma A disorder which is characterised by increased pressure within the eyeball. This occurs secondary to the chronic blockage of normal fluid circulation within the eye. Increased pressure within the eye can cause damage to the optic nerve and eventual blindness. Glaucoma is the leading cause of blindness.
Symptoms include decreased vision, halos around lights (worse at night) and mild chronic headaches. Treatment is generally with beta-blocker eyedrops.
(27 Sep 1997)
chronic glomerulonephritis Glomerulonephritis that presents with persisting proteinuria, chronic renal failure, and hypertension, of insidious onset or as a late sequel of acute glomerulonephritis; the kidneys are symmetrically contracted and granular, with scarring and loss of glomeruli and the presence of tubular atrophy and interstitial fibrosis.
Synonym: chronic nephritis.
(05 Mar 2000)
chronic granulocytic leukaemia <haematology> A leukaemia which is initially slowly-progressing. There are approximately 650 new cases each year in the UK. It is characterised by the presence of large numbers of abnormal mature granulocytes, circulating in the blood.
Synonym: chronic granulocytic leukaemia.
Acronym: CML
Origin: Gr. Haima = blood
(12 Jan 1998)
chronic granulomatous disease <disease> Chronic granulomatous disease is usually fatal in childhood, in which the production of hydrogen peroxide by phagocytes does not occur because of a lesion in an NADP dependent oxidase.
Catalase negative bacteria are not killed and there is no luminol enhanced chemiluminescence when the cells are tested. The absence of the oxygen dependent killing mechanism is not itself fatal but seriously compromises the primary defense system.
at least three separate lesions can cause the syndrome, the commonest being a defect in plasma membrane cytochrome.
Acronym: CGD
(12 Jan 1998)
chronic granulomatous disease of childhood <radiology> Disorder of phagocytosis, two forms: X-linked recessive, autosomal recessive, usually fatal in childhood, infection by nonpathogenic organisms (catalase positive), pneumonia, osteomyelitis, diarrhoea, abdominal pain Findings: recurrent pneumonia (resolves incompletely, with abscess formation), adenopathy (big hila), hepatosplenomegaly, calcified granulomata in liver, spleen, lymph nodes, gastric antral narrowing (!) Cf: Chediak-Higashi syndrome More info: chronic granulomatous disease
(12 Dec 1998)
chronic haemorrhagic villous synovitis <radiology> Monoarthritis, young adults, erosions on BOTH sides of joint (!), probably inflammatory, haemosiderin deposited in synovium, articular cartilage preserved (despite extensive marginal erosions; similar to gout), NO calcification Differential diagnosis: TB (associated atrophy of muscle and bone), rheumatoid arthritis (symmetrical), synovial sarcoma (with or without calcified; outside joint), synovial osteochondromatosis
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
ÅëÇÕ°Ë»ö ¿Ï·á